Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients
File version
Accepted Manuscript (AM)
Author(s)
Graham, Nicolette
Kleidon, Tricia
Ullman, Amanda
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
This study describes a successful, targeted intervention in central venous access device routine care to decrease central line–associated bloodstream infection. Taurolidine–citrate locks significantly reduced the rate of central line–associated bloodstream infection, particularly Gram-negative organisms without adverse events.
Journal Title
Pediatric Infectious Disease Journal
Conference Title
Book Title
Edition
Volume
38
Issue
1
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2019 Lippincott Williams & Wilkins. This is a non-final version of an article published in final form in the Pediatric Infectious Disease Journal, Volume 38 - Issue 1 - p e16–e18. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal link for access to the definitive, published version.
Item Access Status
Note
Access the data
Related item(s)
Subject
Paediatrics
Health services and systems
Public health
Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
Persistent link to this record
Citation
Clark, JE; Graham, N; Kleidon, T; Ullman, A, Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients, Pediatric Infectious Disease Journal, 2019, 38 (1), pp. E16-E18